| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954090 | Biochimie | 2018 | 5 Pages |
Abstract
These results, in accordance with our previous findings, support the role of ZNF224 in imatinib responsiveness and shed new insights into potential therapeutic use of ZNF224 in imatinib-resistant chronic myelogenous leukemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Gaetano Sodaro, Giancarlo Blasio, Federica Fiorentino, Patrick Auberger, Paola Costanzo, Elena Cesaro,